Manatt Health
State Biomarker Testing Laws Boost Medicaid Access, But Gaps Persist
Manatt's analysis of five early-adopting states (Arizona, California, Florida, Illinois, Texas) finds that state laws requiring coverage of biomarker testing modestly increased testing rates among Medicaid enrollees with lung cancer, bucking a national downward trend. However, the report notes that legislation alone isn't sufficient—disparities persist for older, female, and fee-for-service enrollees—suggesting Medicaid managed care plans and state agencies need complementary provider education and utilization management strategies to close access gaps.
This is outside commentary from Manatt Health, not part of Medicaid Monitor's independently scored news coverage.